Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $18,900 | 4 | 38.5% |
| Consulting Fee | $14,769 | 7 | 30.1% |
| Honoraria | $10,599 | 5 | 21.6% |
| Travel and Lodging | $3,359 | 19 | 6.8% |
| Food and Beverage | $1,497 | 16 | 3.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $24,037 | 12 | $0 (2023) |
| Novocure Inc. | $9,491 | 15 | $0 (2019) |
| Blue Earth Diagnostics Limited | $7,485 | 8 | $0 (2020) |
| Varian Medical Systems, Inc. | $3,375 | 8 | $0 (2019) |
| GE HealthCare | $3,270 | 2 | $0 (2022) |
| Bard Peripheral Vascular, Inc. | $999.00 | 2 | $0 (2023) |
| Elekta, Inc. | $139.52 | 1 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $129.49 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $102.79 | 1 | $0 (2019) |
| Augmenix, Inc. | $93.82 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $25,176 | 15 | PFIZER INC. ($24,037) |
| 2022 | $3,270 | 2 | GE HealthCare ($3,270) |
| 2020 | $75.00 | 1 | Blue Earth Diagnostics Limited ($75.00) |
| 2019 | $12,969 | 24 | Novocure Inc. ($9,491) |
| 2018 | $1,366 | 4 | Blue Earth Diagnostics Limited ($1,272) |
| 2017 | $6,268 | 5 | Blue Earth Diagnostics Limited ($6,138) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/30/2023 | PFIZER INC. | XTANDI (Drug) | — | Cash or cash equivalent | $1,150.00 | Research |
| Study: A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES • Category: ONCOLOGY | ||||||
| 10/25/2023 | PFIZER INC. | XTANDI (Drug) | — | Cash or cash equivalent | $10,250.00 | Research |
| Study: A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES • Category: ONCOLOGY | ||||||
| 10/25/2023 | PFIZER INC. | XTANDI (Drug) | — | Cash or cash equivalent | $4,000.00 | Research |
| Study: A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES • Category: ONCOLOGY | ||||||
| 10/25/2023 | PFIZER INC. | XTANDI (Drug) | — | Cash or cash equivalent | $3,500.00 | Research |
| Study: A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES • Category: ONCOLOGY | ||||||
| 10/06/2023 | PFIZER INC. | ORGOVYX (Drug) | Consulting Fee | Cash or cash equivalent | $4,410.00 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2023 | Elekta, Inc. | ELEKTA MEDICAL LINEAR ACCELERATOR (Device) | Food and Beverage | In-kind items and services | $139.52 | General |
| Category: LINAC SOLUTIONS (LINAC) | ||||||
| 10/02/2023 | Bard Peripheral Vascular, Inc. | — | Honoraria | Cash or cash equivalent | $599.00 | General |
| 10/01/2023 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $118.40 | General |
| 08/16/2023 | PFIZER INC. | ORGOVYX (Drug) | Travel and Lodging | Cash or cash equivalent | $99.98 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2023 | PFIZER INC. | ORGOVYX (Drug) | Travel and Lodging | In-kind items and services | $254.81 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2023 | PFIZER INC. | ORGOVYX (Drug) | Travel and Lodging | In-kind items and services | $168.98 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2023 | PFIZER INC. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $35.08 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2023 | PFIZER INC. | ORGOVYX (Drug) | Travel and Lodging | In-kind items and services | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2023 | PFIZER INC. | ORGOVYX (Drug) | Travel and Lodging | In-kind items and services | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 04/28/2023 | Bard Peripheral Vascular, Inc. | — | Honoraria | Cash or cash equivalent | $400.00 | General |
| 09/02/2022 | GE HealthCare | — | Consulting Fee | Cash or cash equivalent | $3,234.00 | General |
| 09/02/2022 | GE HealthCare | — | Travel and Lodging | Cash or cash equivalent | $36.00 | General |
| 04/09/2020 | Blue Earth Diagnostics Limited | Axumin (Drug) | Consulting Fee | Cash or cash equivalent | $75.00 | General |
| Category: Diagnostic Imaging | ||||||
| 11/07/2019 | Novocure Inc. | Oncology (Device) | Travel and Lodging | Cash or cash equivalent | $44.92 | General |
| Category: Optune | ||||||
| 11/07/2019 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $27.96 | General |
| Category: Optune | ||||||
| 11/03/2019 | Varian Medical Systems, Inc. | Edge (Device) | Travel and Lodging | In-kind items and services | $94.00 | General |
| Category: Devices | ||||||
| 11/03/2019 | Varian Medical Systems, Inc. | Edge (Device) | Travel and Lodging | In-kind items and services | $24.09 | General |
| Category: Devices | ||||||
| 11/02/2019 | Varian Medical Systems, Inc. | Edge (Device) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: Devices | ||||||
| 11/02/2019 | Varian Medical Systems, Inc. | Edge (Device) | Travel and Lodging | In-kind items and services | $356.01 | General |
| Category: Devices | ||||||
| 11/02/2019 | Varian Medical Systems, Inc. | Edge (Device) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: Devices | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES | PFIZER INC. | $18,900 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 645 | 1,559 | $761,038 | $123,491 |
| 2022 | 14 | 531 | 1,108 | $490,030 | $77,916 |
| 2021 | 17 | 743 | 1,753 | $778,096 | $130,815 |
| 2020 | 14 | 431 | 916 | $409,908 | $68,460 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 42 | 153 | $224,910 | $24,215 | 10.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 66 | 647 | $119,695 | $23,126 | 19.3% |
| 55875 | Insertion of needle or tube into prostate for radiation therapy | Facility | 2023 | 11 | 19 | $49,608 | $12,480 | 25.2% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 31 | 32 | $55,392 | $11,061 | 20.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 75 | 75 | $57,123 | $10,392 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 91 | 122 | $50,934 | $8,587 | 16.9% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 51 | 52 | $65,879 | $7,375 | 11.2% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 31 | 33 | $30,657 | $6,122 | 20.0% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 39 | 133 | $18,900 | $3,654 | 19.3% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 42 | 75 | $19,250 | $3,603 | 18.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 28 | 32 | $19,451 | $3,575 | 18.4% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 12 | 12 | $11,148 | $2,226 | 20.0% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 25 | 31 | $10,478 | $2,106 | 20.1% |
| 77470 | Special radiation treatment | Facility | 2023 | 20 | 20 | $8,800 | $1,768 | 20.1% |
| 76965 | Ultrasonic guidance for administration of radiation therapy | Facility | 2023 | 11 | 19 | $5,529 | $1,035 | 18.7% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 23 | 51 | $4,284 | $763.65 | 17.8% |
| 77332 | Design and construction of simple radiation treatment device | Facility | 2023 | 25 | 31 | $3,038 | $590.70 | 19.4% |
| 55876 | Placement of device in prostate for radiation therapy | Facility | 2023 | 11 | 11 | $4,356 | $557.86 | 12.8% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 11 | 11 | $1,606 | $255.34 | 15.9% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 28 | 80 | $121,047 | $12,089 | 10.0% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 57 | 319 | $59,015 | $11,318 | 19.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 74 | 74 | $56,092 | $10,030 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 96 | 136 | $56,576 | $9,565 | 16.9% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 22 | 22 | $38,082 | $7,647 | 20.1% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 37 | 37 | $46,805 | $5,209 | 11.1% |
About Dr. Abhishek Solanki, M.D
Dr. Abhishek Solanki, M.D is a Radiation Oncology healthcare provider based in Maywood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2009. The National Provider Identifier (NPI) number assigned to this provider is 1760612808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abhishek Solanki, M.D has received a total of $49,123 in payments from pharmaceutical and medical device companies, with $25,176 received in 2023. These payments were reported across 51 transactions from 10 companies. The most common payment nature is "" ($18,900).
As a Medicare-enrolled provider, Solanki has provided services to 2,350 Medicare beneficiaries, totaling 5,336 services with total Medicare billing of $400,682. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Radiation Oncology
- Location Maywood, IL
- Active Since 07/23/2009
- Last Updated 04/23/2021
- Taxonomy Code 2085R0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760612808
Products in Payments
- XTANDI (Drug) $18,900
- Oncology (Device) $9,491
- Axumin (Drug) $7,485
- ORGOVYX (Drug) $5,019
- Edge (Device) $3,375
- ELEKTA MEDICAL LINEAR ACCELERATOR (Device) $139.52
- PROVENGE (Drug) $129.49
- Erleada (Drug) $102.79
- SpaceOAR (Device) $93.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Maywood
Dr. Matthew Harkenrider, M.d, M.D
Radiation Oncology — Payments: $18,214
Nagendra Koneru, M.d, M.D
Radiation Oncology — Payments: $13,419
James Welsh, Ms Md, MS MD
Radiation Oncology — Payments: $8,830
Bahman Emami, Md, MD
Radiation Oncology — Payments: $4,666
Courtney Hentz, Md, MD
Radiation Oncology — Payments: $1,005
Edward Melian, Md, MD
Radiation Oncology — Payments: $285.05